A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans
Name
pgad317.pdf
Description
Published version
Size
1.26 MB
Format
Adobe PDF
Checksum (MD5)
76a3e230d408db147cfe53af86112207
Author(s) • • • • • • • • •
Chandran Suja, Vineeth
Qi, Qin M
Halloran, Kevin
Zhang, Jifeng
Shaha, Suyog
Prakash, Supriya
Kumbhojkar, Ninad
Deslandes, Antoine
Huille, Sylvain
Gokarn, Yatin R
Date Issued
October 9, 2023
Journal
PNAS Nexus
Publisher
Oxford University Press
Citation
Vineeth Chandran Suja, Qin M Qi, Kevin Halloran, Jifeng Zhang, Suyog Shaha, Supriya Prakash, Ninad Kumbhojkar, Antoine Deslandes, Sylvain Huille, Yatin R Gokarn, Samir Mitragotri, A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans, PNAS Nexus, Volume 2, Issue 10, October 2023, pgad317.
Version
Final published version
Abstract
Subcutaneous (subQ) injection is a common route for delivering biotherapeutics, wherein pharmacokinetics is largely influenced by drug transport in a complex subQ tissue microenvironment. The selection of good drug candidates with beneficial pharmacokinetics for subQ injections is currently limited by a lack of reliable testing models. To address this limitation, we report here a Subcutaneous Co-Culture Tissue-on-a-chip for Injection Simulation (SubCuTIS). SubCuTIS possesses a 3D coculture tissue architecture, and it allows facile quantitative determination of relevant scale independent drug transport rate constants. SubCuTIS captures key in vivo physiological characteristics of the subQ tissues, and it differentiates the transport behavior of various chemically distinct molecules. We supplemented the transport measurements with theoretical modeling, which identified subtle differences in the local absorption rate constants of seven clinically available mAbs. Accounting for first-order proteolytic catabolism, we established a mathematical framework to assess clinical bioavailability using the local absorption rate constants obtained from SubCuTIS. Taken together, the technology described here broadens the applicability of organs-on-chips as a standardized and easy-to-use device for quantitative analysis of subQ drug transport.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivatives
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1093/pnasnexus/pgad317